Literature DB >> 15692647

[Pap smear, hybrid capture II, and visual inspection in screening for uterine cervical lesions].

Renata Clementino Gontijo1, Sophie Françoise Mauricette Derchain, Eliana Borin Lopes Montemor, Luis Otávio Zanatta Sarian, Márcia Milena Pivatto Serra, Luiz Carlos Zeferino, Kari Juhani Syrjanen.   

Abstract

The objective of this study was to evaluate alterations in Pap smear, hybrid capture II (HCII), and visual inspection with acetic acid (VIA) in 684 women treated at a primary health care unit. The performance and agreement of the exams were evaluated. The study also described social, demographic, and reproductive factors and their association with uterine cervical lesions. Women had specimens taken for Pap smear, HCII, and VIA. When at least one of the tests was positive, colposcopy was performed and targeted biopsies were taken from any suspicious lesions. Performance of tests was evaluated. Women's distribution in relation to social, demographic, and reproductive factors and histological diagnosis was evaluated using the odds ratio. Among 198 women with at least one positive screening test, only 21 showed histological disease. Sensitivities of the tests were similar. VIA and Pap smear presented higher specificity than HCII. Only absence of a previous Pap smear was associated with the presence of histological disease. Pap smear performed better than VIA and HC II. Absence of previous cytology was associated with histological disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15692647     DOI: 10.1590/s0102-311x2005000100016

Source DB:  PubMed          Journal:  Cad Saude Publica        ISSN: 0102-311X            Impact factor:   1.632


  2 in total

1.  Prevalence of human papillomavirus types associated with cervical lesions in Sergipe state, Northeastern Brazil: high frequency of a possibly carcinogenic type.

Authors:  I G S S Serra; E D Araujo; G S Barros; F L S G Santos; R Q Gurgel; M V A Batista
Journal:  Epidemiol Infect       Date:  2018-05-21       Impact factor: 4.434

2.  Cervical cancer screening coverage in a high-incidence region.

Authors:  Cibelli Navarro; Allex Jardim da Fonseca; Alexander Sibajev; Camila Iasmim de Andrade Souza; Daniela Souza Araújo; Daniele Aparecida de Freitas Teles; Stéphanie Gomes Lins de Carvalho; Kyldery Wendell Moura Cavalcante; Wendell Lima Rabelo
Journal:  Rev Saude Publica       Date:  2015-02-27       Impact factor: 2.106

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.